Abstract
It was demonstrated that the influence of i.v. administered probenecid on HVA concentration in CSF was less pronounced in a group of retarded depression than in a group of non-retarded depression and a non-depressive control group. The figures corresponded to that found in Parkinson patients.
These findings suggest a decreased consumption of dopamine in the brain in retarded depression. This might be understood as an indication that, disorders of cerebral dopamine metabolism are related not so much to a specific nosological entity as to a given motor status, possibly that of hypokinesia.
Literature
Bowers, M. B., Jr., Gerbode, F.: CSF 5-HIAA: Effects of probenecid and parachlorophenylalanine. Life Sci. 7, 773 (1968).
Bunney, W. E., Davis, J. M.: Norepinephrine in depressive reactions. Arch. gen. Psychiat. 13, 483 (1965).
Chase, T. N., Schuur, J. A., Gordon, E. K.: Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacol. 9, 265 (1970).
Cotziaz, G. C., Woert, H. M. van, Schiffer, L.: Aromatic amino acids and modification of parkinsonism. New Engl. J. Med. 276, 374 (1967).
Curzon, G., Godwin-Austen, R. B., Tomlinson, E. B., Kantamaneni, B. D.: The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-Dopa. J. Neurol. Neurosurg. Psychiat. 33, 1 (1970).
Everett, G. M., Borcherding, J. W.: L-Dopa: Effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice. Science 168, 849 (1970).
Forn, J., Maling, H. M., Gessa, J. L.: Homovanillic and 5-hydroxyindoleacetic acids in cerebrospinal fluid after probenecid: Measurement of brain monoamine oxidase inhibition in vivo. Proc. Soc. exp. Biol. (N. Y.) 133, 1310 (1970).
Goodwin, F. K., Brodie, H. K. H., Murphy, D. L., Bunney, W. E.: Administration of a peripheral decarboxylase inhibitor with l-Dopa to depressed patients. Lancet 1970 I, 908.
Guldberg, H. C.: Metabolism of amines in the brain. Changes in amine metabolite concentrations in cerebrospinal fluid as an index turnover. In: G. Hooper (Ed.). London: MacMillan 1969.
—, Turner, J. W., Hanich, A., Ashcroft, G. W., Crawford, T. B. B., Perry, W. L. M., Gellingham, F.J.: On the occurrence of homovanillic acid and 5-hydroxyindole- 3-ylacetic acid in the ventricular CSP of patients suffering from Parkonsonism. Confin. neurol. (Basel) 29, 73 (1967).
Hornykiewicz, O.: Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der substantia nigra des normalen und Parkinsonkranken Menschen. Wien. klin. Wschr. 75, 309 (1963).
Johansson, B., Roos, B.-E.: 5-Hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome. Life Sci. 6, 1449 (1967).
Korf, J., Ottema, S., Veen, I. van der: Fluorimetric determination of homovanillic acid in biological material after isolation on sephadex G 10. Analyt. Biochem. (in press).
—, Praag, H. M. van: The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depression. Psychopharmacologia 18, 129 (1970).
Neff, N. H., Tozer, T. N., Brodie, B. B.: Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. exp. Ther. 158, 214 (1967).
Olsson, R., Roos, B.-E.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature (Lond.) 219, 502 (1968).
Praag, H. M. van: Antidepressants, catecholamines and 5-hydroxyindoles. Trends towards a more specific research in the field of antidepressants. Psychiat. Neurol. Neurochir. 70, 219 (1967).
—, Korf, J., Puite, J.: 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (Lond.) 225, 1259(1970).
- - A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol. Psychiat. (in press).
Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: A review of supporting evidence. Amer. J. Psychiat. 122, 509 (1965).
Werdinius, B.: Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta pharmacol. (Kbh.) 25, 18 (1967).
Author information
Authors and Affiliations
Additional information
This study was supported by grants from the Netherlands Organization for Pure Research (Z.W.O.).
Rights and permissions
About this article
Cite this article
van Praag, H.M., Korf, J. Retarded depression and the dopamine metabolism. Psychopharmacologia 19, 199–203 (1971). https://doi.org/10.1007/BF00402643
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402643